The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Sept 14 Board Meeting Agenda item 15d Young pharmacists and EU funding
Since last Meeting
After the General Assembly the PAO worked with Nenad Miljkovic of the Serbian association to identify potential EU funding pools that may match with the original objectives of the proposal presented. 3 potential opportunities were identified, and a call to EAHP's member network for interest was issued in July. More information here.
Following the close of this call in August, conversations were held with those who expressed interest that had prior experience of making bids for EU funding. The advice received was that, to stand a reasonable chance of success, EAHP should partner with interests outside of hospital pharmacy, to maximise the strength of the bid. A series of phonecalls and emails to potential organisations with potential similar interests were made, to which PGEU made a very favourable response – particularly in relation to the Health Programme's call on adherence, frailty, integrated care and multi-chronic conditions (3m euro available).
At the time of writing PGEU and EAHP are preparing a bid of 7 work packages to meet this call, likely to total around 1m euro for all partners. Approximately 120,000 euros over three years may be sought by EAHP for its leadership in work packages relating to medicines reconciliation and inter sector communication. Further information about the work packages under development is available here. To note, these work packages are developing day by day in the run up to the 25 September submission deadline. EPHA and AIM are confirmed in their interest in participation. EAFP, EUGMS and the geriatric section of UEMS are waiting some final internal sign off, but have otherwise signalled interest.
Board Member comment on the work package concepts is welcomed. The PAO will give a further verbal briefing at the meeting.
Some discussion is also being had between Maastricht and Birmingham Children's hospital pharmacies about whether any opportunities for hospital pharmacy projects exist in relation to the Horizon 2020 call on paediatric interventions. However, as yet, no concrete agrement on the nature of such a project has been established.